Conference call to discuss Crovalimab in Hematology and Nephrology in conjunction with EHA 2023 will be held on June 12 at 10:30 am. (Webcast Link):(https://visualizing-ideas.zoom.us/webinar/register/WN_5lU4NSOXTeiWrMwf3DHAEw#/registration)
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on RHHBY:
- Roche awarded WHO prequalification for the cobas® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries
- New data show Roche’s subcutaneously administered crovalimab achieved disease control and was well-tolerated in people with paroxysmal nocturnal haemoglobinuria (PNH)
- Roche to present new data in blood cancers and solid tumours from its broad portfolio at ASCO 2023
- Roche’s BTK inhibitor fenebrutinib significantly reduced brain lesions in people with relapsing forms of multiple sclerosis
- FDA accepts application for Roche’s Vabysmo for the treatment of retinal vein occlusion (RVO)